Atypical dementias: from diagnosis to emerging therapies
ICGEB
14 episodes
5 months ago
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community.
The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.
All content for Atypical dementias: from diagnosis to emerging therapies is the property of ICGEB and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community.
The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.
Federico Ranieri, Rome, Italy speaks on "The contribution of non-invasive brain stimulation in the diagnosis and management of dementia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Marco Onofrj, Chieti, Italy speaks on "EEG in Dementia with Lewy Body". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Zuzana Walker, UCL, UK London on "Progress in diagnosis of Dementia with Lewy Bodies". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Zachary Miller, San Francisco, USA speaks on "Co-occurrence of autoimmune disease within atypical dementias". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Amalia Bruni, Lamezia Terme, Italy speaks on "Niemann-pick C: when diseases don't respect borders". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Gianluigi Zanusso, Verona, Italy speaks on "Advances in human prion disorders diagnosis". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Alessandro Padovani, Brescia, Italy speaks on "The emerging picture of early Alzheimer's Disease". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Fabrizio Tagliavini, Milan, Italy speaks on "New insights into Cerebral Amyloid Angiopathy". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Bruno Dubois, Paris, France speaks on "New criteria of Alzheimer Disease: the atypical cases". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Pietro Fratta, London, UK speaks on "TDP-43: C-terminal mutations induce a splicing gain of function". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
James Rowe, Cambridge, UK speaks on "Neuroimaging in Frontotemporal Dementia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Ian Mackenzie, Vancouver, Canada speaks on "Molecular neuropathology of FTD: recent developments". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Thomas Bak, Edinburgh, UK speaks on "Clinical aspects of Primary Progressive Aphasia". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Peter Heutink, Tubingen, Germany speaks on "Risk and Modifying factots in to Fronto Temporal Dementia (RiMod-FTD)". This movie has been recorded at "Atypical dementias: from diagnosis to emerging therapies" conference.
Atypical dementias: from diagnosis to emerging therapies
Dementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years. At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, progressive nuclear palsy and Parkinson dementia. Often, these atypical dementias are associated with neurological symptoms and with motor neuron disease. Understanding the molecular basis of these dementias, their diagnosis, clinical implications, and diagnostic issues, currently represents one of the most pressing issues worldwide. For this reason, the meeting topics are of high interest for the whole scientific community.
The meeting will foster targeted emerging areas of research in this field. In parallel, it also plans to integrate and disseminate current knowledge on the subject. The subject areas of the Meeting will mostly be concerned with the several forms of atypical dementias that are on the rise in both developed and developing countries. This will particularly include leading conceptual advances that arise from the study of early and late stage pathological neurodegeneration. As a result, the meeting will be positioned to provide invaluable guidance for other scientists, governing bodies, and the general population towards the best ways of lessening the impact of dementia, both at the macro-economical and individual human level.